2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and Head and Neck Neoplasms

2-aminobicyclo(2,2,1)heptane-2-carboxylic acid has been researched along with Head and Neck Neoplasms in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Kanai, Y; Kimura, T; Kohno, N; Nagamori, S; Sakurai, H; Wiriyasermkul, P; Yamauchi, K	1

Other Studies

1 other study(ies) available for 2-aminobicyclo(2,2,1)heptane-2-carboxylic acid and Head and Neck Neoplasms

Article	Year
System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line. Cancer letters, 2009, Apr-08, Volume: 276, Issue:1 Topics: Amino Acids, Cyclic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Synergism; Fusion Regulatory Protein 1, Heavy Chain; Head and Neck Neoplasms; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Protein Kinases; TOR Serine-Threonine Kinases	2009

Article

Year

System L amino acid transporter inhibitor enhances anti-tumor activity of cisplatin in a head and neck squamous cell carcinoma cell line.

Cancer letters, 2009, Apr-08, Volume: 276, Issue:1

Topics: Amino Acids, Cyclic; Antineoplastic Combined Chemotherapy Protocols; Blotting, Western; Carcinoma, Squamous Cell; Cell Line, Tumor; Cisplatin; Drug Synergism; Fusion Regulatory Protein 1, Heavy Chain; Head and Neck Neoplasms; Humans; Large Neutral Amino Acid-Transporter 1; Leucine; Protein Kinases; TOR Serine-Threonine Kinases

2009